Development and multicohort evaluation of a KRT5/KRT6A/KRT17-based prognostic scoring system for pancreatic cancer using single-cell RNA sequencing

Due to its insidious onset and lack of effective risk stratification tools, pancreatic cancer (PACA) outcomes remain poor, underscoring the urgent need for an optimized prognostic scoring system. The CRA001160 single-cell RNA-sequencing (scRNA-seq) dataset (24 PACA samples) was used for single-cell analyses. A total of 913 bulk samples from four independent cohorts were included for prognostic score development and multicohort evaluation. Multiplex immunofluorescence using a tissue microarray cohort (TMA, n = 80) was utilized to validate the performance of our prognostic scoring system. Analysis of malignant cells in CRA001160 identified a C8 malignant-cell state with proliferation- and stemness-related programs whose abundance increased across the available TNM stages. Across the bulk cohorts, C8-related features were correlated with poorer survival and classic tumor suppressor TP53 and CDKN2A mutation status. Using three markers of the C8 malignant-cell state, we developed and evaluated a novel prognostic scoring system demonstrating distinct survival outcomes. The results of the TMA and four independent transcriptomic cohorts showed consistent prognostic associations, supporting further evaluation across independent datasets and assay types. Our findings provide insights into PACA intratumoral heterogeneity and illustrate the potential of single-cell analyses for prognostic biomarker development. The KRT5 / KRT6A / KRT17 -based score showed prognostic relevance across retrospective cohorts but requires prospective validation using standardized assays and prespecified thresholds before clinical application.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-11-12
DOI
https://doi.org/10.1186/s12885-026-16974-4
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development and multicohort evaluation of a KRT5/KRT6A/KRT17-based prognostic scoring system for pancreatic cancer using single-cell RNA sequencing

Ruopeng Liang, Yuling Sun, Yin Liu, Lin Zhou et al.
BMC Cancer
Pancreatic and Hepatic Oncology Research
article

Development and multicohort evaluation of a KRT5/KRT6A/KRT17-based prognostic scoring system for pancreatic cancer using single-cell RNA sequencing

Ruopeng Liang, Yuling Sun, Yin Liu, Lin Zhou, Rongtao Zhu, 世涛 吴, Xinwei Han, Libo Wang, Jian Li, Yuyuan Zhang, Jiahui Cao, Weijie Wang
article en

Abstract

Due to its insidious onset and lack of effective risk stratification tools, pancreatic cancer (PACA) outcomes remain poor, underscoring the urgent need for an optimized prognostic scoring system. The CRA001160 single-cell RNA-sequencing (scRNA-seq) dataset (24 PACA samples) was used for single-cell analyses. A total of 913 bulk samples from four independent cohorts were included for prognostic score development and multicohort evaluation. Multiplex immunofluorescence using a tissue microarray cohort (TMA, n = 80) was utilized to validate the performance of our prognostic scoring system. Analysis of malignant cells in CRA001160 identified a C8 malignant-cell state with proliferation- and stemness-related programs whose abundance increased across the available TNM stages. Across the bulk cohorts, C8-related features were correlated with poorer survival and classic tumor suppressor TP53 and CDKN2A mutation status. Using three markers of the C8 malignant-cell state, we developed and evaluated a novel prognostic scoring system demonstrating distinct survival outcomes. The results of the TMA and four independent transcriptomic cohorts showed consistent prognostic associations, supporting further evaluation across independent datasets and assay types. Our findings provide insights into PACA intratumoral heterogeneity and illustrate the potential of single-cell analyses for prognostic biomarker development. The KRT5 / KRT6A / KRT17 -based score showed prognostic relevance across retrospective cohorts but requires prospective validation using standardized assays and prespecified thresholds before clinical application.

BMC Cancer
Tianjin Medical University Cancer Institute and Hospital (CN), Zhengzhou University (CN), First Affiliated Hospital of Zhengzhou University (CN)
National Natural Science Foundation of China
Good health and well-being
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon